Nisa Investment Advisors
CGON icon

Nisa Investment Advisors’s CG Oncology CGON Stock Holding History

Nisa Investment Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.2K Buy
1,288
+559
+77% +$31.7K ﹤0.01% 1477
2025
Q4 		$30.3K Buy
729
+6
+0.8% +$248 ﹤0.01% 1788
2025
Q3 		$29.1K Sell
723
-26
-3% -$756 ﹤0.01% 1828
2025
Q2 		$19.5K Buy
749
+699
+1,398% +$16.8K ﹤0.01% 1948
2025
Q1 		$1.23K Sell
50
-19
-28% -$534 ﹤0.01% 2582
2024
Q4 		$1.98K Buy
69
+1
+1% +$34 ﹤0.01% 2489
2024
Q3 		$2.57K Buy
68
+22
+48% +$771 ﹤0.01% 2348
2024
Q2 		$1.45K Buy
46
+41
+820% +$1.42K ﹤0.01% 2431
2024
Q1 		$220 Buy
+5
New +$204 ﹤0.01% 2625

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nisa Investment Advisors's CGON Position: Q1 2026 in Review

Nisa Investment Advisors increased its CG Oncology (CGON) stake by 77% in Q1 2026, buying an estimated $31.7K and bringing the position to 1,288 shares worth $87.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Nisa Investment Advisors first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Nisa Investment Advisors held 1,288 shares of CG Oncology worth $87.2K as of Q1 2026.
  • Nisa Investment Advisors bought 559 CG Oncology shares in Q1 2026, an estimated $31.7K.
  • CG Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1477 holding.
  • Nisa Investment Advisors first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.